ROBERT HOFFMAN Insider Trading Transactions
Get free email notifications about insider trading for ROBERT HOFFMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT HOFFMAN. ROBERT HOFFMAN is CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in CombiMatrix Corp ($CBMX) and CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and Director in Kura Oncology, Inc. ($KURA) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in Aravive, Inc. ($VSAR).
Latest Insider Trading Transactions of ROBERT HOFFMAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, ARNA, CBMX, HRTX, INNV, KTRA, KURA, MBVX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
Sep 17 2020 | DMPI | Kintara Therapeuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.70 | 120,000 | 204,000 | 120,000 | |
Jun 30 2020 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 75,000 | |
Jun 26 2020 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
Dec 23 2019 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 25.02 | 100,000 | 2,502,000 | 100,000 | |
Sep 13 2019 | ARAV | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | A | 5.77 | 7,500 | 43,275 | 7,500 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 35,433 | 21,614 | 35,433 | |
Sep 09 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 39,567 | 24,136 | 39,567 | |
Jun 27 2019 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
May 01 2019 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Jan 07 2019 | VSAR | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | A | 3.69 | 4,688 | 17,299 | 4,688 | |
Jan 07 2019 | VSAR | Aravive, Inc. | HOFFMAN ROBERT | Director | Option Exercise | A | 3.69 | 7,500 | 27,675 | 7,500 | |
Dec 18 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 24.97 | 71,000 | 1,772,870 | 71,000 | |
Nov 13 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.61 | 40,000 | 24,396 | 40,000 | |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | M | 15.30 | 30,000 | 459,000 | 100,000 | |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | S | 38.80 | 1,060 | 41,123 | 1,280 | 2.3 K to 1.3 K (-45.30 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Sell | S | 38.15 | 28,940 | 1,104,107 | 2,340 | 31.3 K to 2.3 K (-92.52 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | M | 15.30 | 30,000 | 459,000 | 31,280 | 1.3 K to 31.3 K (+2,343.75 %) |
Jul 03 2018 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | J | 13.22 | 744 | 9,834 | 1,280 | 536 to 1.3 K (+138.81 %) |
Jun 08 2018 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 16.35 | 13,000 | 212,550 | 13,000 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
Apr 17 2018 | DMPI | DelMar Pharmaceuti ... | HOFFMAN ROBERT | Director | Option Exercise | A | 1.06 | 36,000 | 38,160 | 36,000 | |
Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 17.00 | 56,667 | 963,339 | 56,667 | |
Dec 20 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Buy | J | 13.05 | 536 | 6,993 | 536 | 0 to 536 |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Option Exercise | U | 46.80 | 1,619 | 75,769 | 0 | |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Sell | U | 0.00 | 6,618 | 0 | 0 | 6.6 K to 0 (-100.00 %) |
Nov 16 2017 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Sell | D | 0.00 | 2,001 | 0 | 6,618 | 8.6 K to 6.6 K (-23.22 %) |
Jun 12 2017 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 8.60 | 10,000 | 86,000 | 10,000 | |
May 23 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | A | 1.80 | 50,000 | 90,000 | 50,000 | ||
Apr 24 2017 | HRTX | HERON THERAPEUTICS ... | HOFFMAN ROBERT | CFO & SVP, Finance | Option Exercise | A | 15.30 | 130,000 | 1,989,000 | 130,000 | |
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | M | 0.00 | 1,543 | 0 | 1,543 | ||
Apr 04 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Buy | M | 0.00 | 1,543 | 0 | 4,438 | 2.9 K to 4.4 K (+53.30 %) | |
Jan 03 2017 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | A | 3.38 | 4,100 | 13,858 | 4,100 | ||
Nov 21 2016 | INNV | INNOVUS PHARMACEUT ... | HOFFMAN ROBERT | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 2,500,000 | 0 | 2,500,000 | |
Aug 30 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | A | 5.00 | 4,100 | 20,500 | 4,100 | ||
Jul 28 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | A | 0.55 | 35,000 | 19,250 | 35,000 | ||
May 13 2016 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 3.12 | 10,000 | 31,200 | 10,000 | |
May 10 2016 | CBMX | CombiMatrix Corp | HOFFMAN ROBERT | Director | Buy | P | 3.19 | 5,000 | 15,963 | 7,409 | 2.4 K to 7.4 K (+207.56 %) |
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | M | 0.00 | 11,417 | 0 | 22,833 | ||
Apr 05 2016 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Buy | M | 0.00 | 11,417 | 0 | 21,417 | 10 K to 21.4 K (+114.17 %) | |
Aug 27 2015 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Option Exercise | A | 1.52 | 35,000 | 53,200 | 35,000 | ||
Apr 27 2015 | KURA | Kura Oncology, Inc ... | HOFFMAN ROBERT | Director | Option Exercise | A | 6.32 | 30,000 | 189,600 | 30,000 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Option Exercise | M | 1.48 | 50,000 | 74,000 | 150,000 | |
Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Sell | S | 8.32 | 50,000 | 415,980 | 3,382 | 53.4 K to 3.4 K (-93.66 %) |
Oct 02 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Buy | M | 1.48 | 50,000 | 74,000 | 53,382 | 3.4 K to 53.4 K (+1,478.42 %) |
Jul 09 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | SVP, Finance and CF ... | Sell | S | 11.00 | 10,000 | 110,000 | 2,763 | 12.8 K to 2.8 K (-78.35 %) |
Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 1.81 | 285,000 | 515,850 | 285,000 | |
Jan 10 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | J | 1.63 | 150 | 245 | 12,144 | 12.3 K to 12.1 K (-1.22 %) |
Jan 10 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Buy | J | 1.64 | 150 | 246 | 12,294 | 12.1 K to 12.3 K (+1.24 %) |
Sep 15 2011 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 1.48 | 200,000 | 296,000 | 200,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 3.25 | 65,000 | 211,250 | 65,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 4.01 | 35,000 | 140,350 | 35,000 | |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.12 | 2,000 | 12,240 | 57,254 | 59.3 K to 57.3 K (-3.38 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.13 | 2,500 | 15,325 | 59,254 | 61.8 K to 59.3 K (-4.05 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.18 | 2,000 | 12,360 | 61,754 | 63.8 K to 61.8 K (-3.14 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.20 | 1,500 | 9,300 | 63,754 | 65.3 K to 63.8 K (-2.30 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.19 | 2,000 | 12,380 | 65,254 | 67.3 K to 65.3 K (-2.97 %) |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 6.99 | 35,000 | 244,650 | 35,000 | |
Feb 15 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Gift | G | 0.00 | 700 | 0 | 66,544 | 67.2 K to 66.5 K (-1.04 %) |
Jul 26 2007 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Gift | G | 0.00 | 1,200 | 0 | 67,039 | 68.2 K to 67 K (-1.76 %) |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 13.50 | 35,000 | 472,500 | 35,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | M | 0.60 | 5,000 | 3,000 | 0 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 10.55 | 2,500 | 26,375 | 66,714 | 69.2 K to 66.7 K (-3.61 %) |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 10.42 | 5,000 | 52,100 | 69,214 | 74.2 K to 69.2 K (-6.74 %) |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Buy | M | 0.60 | 5,000 | 3,000 | 74,214 | 69.2 K to 74.2 K (+7.22 %) |
Apr 04 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Buy | J | 3.75 | 625 | 2,344 | 68,622 | 68 K to 68.6 K (+0.92 %) |
Jan 24 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 16.80 | 40,000 | 672,000 | 40,000 | |
Jan 24 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Grant | A | 0.00 | 15,000 | 0 | 67,997 | 53 K to 68 K (+28.30 %) |
Jan 03 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | CFO & CAO | Buy | J | 3.75 | 320 | 1,200 | 52,997 | 52.7 K to 53 K (+0.61 %) |
Dec 07 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Gift | G | 0.00 | 200 | 0 | 52,677 | 52.9 K to 52.7 K (-0.38 %) |
Oct 03 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Buy | J | 3.75 | 223 | 836 | 52,877 | 52.7 K to 52.9 K (+0.42 %) |
Jul 01 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Buy | J | 3.75 | 140 | 525 | 52,654 | 52.5 K to 52.7 K (+0.27 %) |
Apr 01 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Buy | J | 3.75 | 367 | 1,376 | 52,514 | 52.1 K to 52.5 K (+0.70 %) |
Jan 18 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Option Exercise | A | 6.16 | 30,000 | 184,800 | 30,000 | |
Jan 04 2005 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Buy | J | 3.75 | 127 | 476 | 52,147 | 52 K to 52.1 K (+0.24 %) |
Oct 04 2004 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance & CAO | Buy | J | 3.66 | 150 | 549 | 52,020 | 51.9 K to 52 K (+0.29 %) |
Jul 02 2004 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance | Buy | J | 4.64 | 103 | 478 | 51,870 | 51.8 K to 51.9 K (+0.20 %) |
Apr 02 2004 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance | Buy | J | 5.45 | 108 | 589 | 51,767 | 51.7 K to 51.8 K (+0.21 %) |
Page: 1